CA 19-9 Antikörper
(2 Referenzen)-
- Target Alle CA 19-9 Antikörper anzeigen
- CA 19-9 (Gastrointestinal Cancer Antigen CA19-9 (CA 19-9))
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser CA 19-9 Antikörper ist unkonjugiert
-
Applikation
- ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunohistochemistry (Frozen Sections) (IHC (fro)), Radioimmunoassay (RIA)
- Verwendungszweck
- Mouse monoclonal antibody raised against CA 19-9.
- Spezifität
- This antibody reacts with cancer antigen CA 19-9.
- Immunogen
- Immunodiffusion precipitate of ovarian cystic mucins with NS19-9-antibody.
- Klon
- 121 SLE
- Isotyp
- IgM
- Top Product
- Discover our top product CA 19-9 Primärantikörper
-
anti-Gastrointestinal Cancer Antigen CA19-9 (CA 19-9) antibody
CA 19-9 Reaktivität: Human ELISA, IHC (p) Wirt: Maus Monoclonal 121SLE unconjugated
anti-Gastrointestinal Cancer Antigen CA19-9 (CA 19-9) antibodyCA 19-9 Reaktivität: Human IHC, StM Wirt: Kaninchen Monoclonal CA19-9-1390R unconjugated
anti-Gastrointestinal Cancer Antigen CA19-9 (CA 19-9) antibodyCA 19-9 Reaktivität: Human ELISA, FACS, IHC (p), IHC (fro), WB Wirt: Maus Monoclonal 121SLE unconjugated
anti-Gastrointestinal Cancer Antigen CA19-9 (CA 19-9) antibodyCA 19-9 Reaktivität: Human IHC, StM Wirt: Maus Monoclonal 121SLE unconjugated
anti-Gastrointestinal Cancer Antigen CA19-9 (CA 19-9) antibodyCA 19-9 Reaktivität: Human IHC, FACS, IF, ISt Wirt: Maus Monoclonal SPM588 unconjugated
anti-Gastrointestinal Cancer Antigen CA19-9 (CA 19-9) antibodyCA 19-9 Reaktivität: Human FACS, IF, IHC (p) Wirt: Kaninchen Monoclonal CA19-9-1390R unconjugated Recombinant Antibody
-
- Applikationshinweise
-
Immunohistochemistry (1:10-1:50)
The optimal working dilution should be determined by the end user. - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 50 μg/mL
- Buffer
- In phosphate buffer, pH 7.3 (0.09 % sodium azide)
- Lagerung
- 4 °C
- Informationen zur Lagerung
- Store at 4°C. Do not freeze.
-
-
: "Preoperative staging of periampullar cancer with US, CT, EUS and CA 19-9." in: Hepato-gastroenterology, Vol. 47, Issue 34, pp. 1135-7, (2001) (PubMed).
: "Tumour markers in malignancies. CA19.9 is useful in several cancers." in: BMJ (Clinical research ed.), Vol. 321, Issue 7257, pp. 380, (2000) (PubMed).
-
: "Preoperative staging of periampullar cancer with US, CT, EUS and CA 19-9." in: Hepato-gastroenterology, Vol. 47, Issue 34, pp. 1135-7, (2001) (PubMed).
-
- Target
- CA 19-9 (Gastrointestinal Cancer Antigen CA19-9 (CA 19-9))
- Andere Bezeichnung
- CA 19-9 (CA 19-9 Produkte)
-
